Business & Investment

ST. PAUL, Minnesota – 3M announced today it has acquired the manufacturing and marketing rights to the PERIDEX^® brand periodontal rinse product from Zila Inc. (NASDAQ:ZILA) for $9.5 million in cash.

SANTA CLARA, California – Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign(R), a proprietary method of straightening teeth without wires and brackets, announced today that Thomas M. Prescott, President and Chief Executive Officer of Align Technology, Inc., is scheduled to speak at the Jefferies Healthcare Conference in New York City on Thursday, June 28, 2007 at 8:40 a.m. ET / 5:40 a.m. PT.

MELVILLE, New York – Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners in the combined North American and European markets, announced today that Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein and Steven Paladino, the Company's Executive Vice President and Chief Financial Officer, will present at the 27th Annual William Blair Growth Stock Conference on Wednesday, June 20, 2007. The Conference is being held at The Four Seasons Hotel in Chicago.

MELVILLE, New York – Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners in the combined North American and European markets, announced today that Graham Stanley, Vice President and Treasurer, will present at the Gabelli & Company, Inc. 5th Annual Dental & Veterinary Conference on Thursday, June 14, 2007. The Conference is being held at The Grand Hyatt Hotel in New York City.

SANTA CLARA, California – Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign^®, a proprietary method of straightening teeth without wires and brackets, announced today that Eldon M. Bullington, Vice President of Finance and Chief Financial Officer of Align Technology, Inc., is scheduled to speak at the NASDAQ 19th Investor Program on Tuesday, June 19, 2007 in London at 8:30 a.m. BST / 3:30 a.m. EDT and Wednesday, June 20, 2007 in Zurich at 4:30 p.m. CEST / 10:30 a.m. EDT.

MELVILLE, New York – Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners in the combined North American and European markets, today announced its intent to make an offer to acquire Software of Excellence International Ltd. (NZX: SOE), a New Zealand publicly listed company with revenue from continuing operations of approximately $19.1 million for its year ended March 31, 2007. Henry Schein intends to offer NZ$2.70 per share to Software of Excellence shareholders, after payment of a dividend of NZ$.03 per share. The combined offer price and dividend represents a 27% premium based on the closing price of SOE shares on April 27, 2007, the last trading day prior to when Software of Excellence made public the disclosure of a potential acquisition. If completed, the total purchase price excluding transaction costs will be NZ$77.2 million (approximately $58.0 million), and is expected to be paid in cash. Henry Schein expects the proposed transaction to be neutral to 2007 earnings and slightly accretive to 2008 earnings.

MELVILLE, New York – Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners in the combined North American and European markets, announced today that Steven Paladino, Henry Schein's Executive Vice President and Chief Financial Officer, will present at the 28th Annual Goldman Sachs Healthcare Conference on Wednesday, June 13, 2007. The Conference is being held at The Ritz-Carlton, Laguna Niguel in California.

WARSAW, Indiana – Biomet, Inc. (NASDAQ:BMET) announced today that it received a letter from the Nasdaq Listing Qualifications Panel stating that Biomet has evidenced compliance with the Panel's prior decisions and all applicable Nasdaq Marketplace Rules, and that the Panel has determined to continue the listing of Biomet’s common shares on the NASDAQ Global Select Market.

WARSAW, Indiana – The Board of Directors of Biomet, Inc. (NASDAQ:BMET), a worldwide leader in the orthopedic and musculoskeletal product industry, announced today that it has unanimously recommended to shareholders an increased offer from a private equity consortium to acquire Biomet for $46.00 per share in cash, or an equity value of $11.4 billion. Under the terms of the revised merger agreement, the consortium – which includes affiliates of the Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Co. and TPG – will commence a tender offer on or before June 14, 2007, to acquire all of the outstanding shares of Biomet’s common stock. Following completion of the tender offer, the consortium will complete a second-step merger in which any remaining common shares of Biomet will be converted into the right to receive the same per share price paid in the tender offer.

WARSAW, Indiana – Biomet, Inc. (NASDAQ:BMET) announced today that two of the Company’s principal officers, Charles E. Niemier and Garry L. England, have informed Biomet of their decisions to retire. Mr. Niemier and Mr. England are 27-year and 26-year veterans of the Company, respectively, and have each held key senior management positions throughout their long tenure at Biomet.